Saccharo
Pre-clinicalThe cancer immune shielding pathway was discovered serendipitously by Saccharo’s co-founder while developing vaccines for bacterial pathogens. He discovered that fetal cells, cancer cells and certain pathogens deployed a similar polysaccharide-based mechanism for evading human immune defenses.
Founded
2021
Focus
AntibodiesBiologicsSmall Molecules
About
The cancer immune shielding pathway was discovered serendipitously by Saccharo’s co-founder while developing vaccines for bacterial pathogens. He discovered that fetal cells, cancer cells and certain pathogens deployed a similar polysaccharide-based mechanism for evading human immune defenses.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2021
LocationBoston, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile